Relationships between thrombohemorrhagic complications and platelet function in patients with essential thrombocythaemia.
Three subgroups have been distinguished in essential thrombocythaemia (ET) patients, on the basis of clinical and laboratory findings. ET patients with bleeding incidents had smaller platelet volume, lower concentrations of beta-thromboglobulin and platelet factor 4 in their plasma, 10%, 26%, and 26% lower compared to patients without complications, respectively. ATP secretion from platelets of bleeders, clotters, and "no-complications" ET patients was found to be 75%, 36%, and 45%, respectively, lower than in healthy people. Spontaneous platelet aggregation appeared to be normal in about 90% of ET patients with no complications and in all bleeders but only in 35% patients with clotting incidents. All bleeders had abnormal agonist-evoked aggregation assays. Among remaining ET patients 30%-60% displayed normal values of different evoked aggregation tests. Thus, clinically distinguished group of bleeding ET patients may be differentiated from other subgroups on the basis of laboratory findings.
Raszeja-Specht
A
A
Department of Clinical Biochemistry, Medical University of Gdańsk, Poland. rasz@amedec.amg.gda.pl
Skibowska
A
A
Bieniaszewska
M
M
Szutowicz
A
A
D000255:Adenosine Triphosphate / Q000097:blood; D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000502:physiology*; D005260:Female; D006470:Hemorrhage / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation; D012016:Reference Values; D013922:Thrombocytosis / Q000097:blood* / Q000150:complications* / Q000378:metabolism; D013927:Thrombosis / Q000209:etiology*; D013928:Thromboxane A2 / Q000097:blood
D013928:Thromboxane A2; D000255:Adenosine Triphosphate